Understanding Parkinson's Disease: A Comprehensive Overview for Healthcare Professionals
OthersPage Navigation
Introduction
Parkinson's Disease (PD) is a progressive neurodegenerative disorder, primarily affecting the motor system. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a wide range of motor and non-motor symptoms. This article provides a broad overview of the pathophysiology, clinical features, diagnosis, and management of PD.
Pathophysiology
The hallmark of PD is the accumulation of alpha-synuclein, a protein that forms clumps known as Lewy bodies, in the brain. The loss of dopaminergic neurons leads to a decrease in dopamine levels, causing an imbalance in the basal ganglia circuits that control movement.
Clinical Features
PD typically presents with motor symptoms like bradykinesia, resting tremor, and rigidity. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, depression, and sleep disturbances can also manifest.
Diagnosis
Diagnosis is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging, although not routinely used, can support the diagnosis.
Management
Management of PD is symptomatic and aims to improve quality of life. Pharmacological treatment includes levodopa, dopamine agonists, and MAO-B inhibitors. Non-pharmacological interventions encompass physical therapy, occupational therapy, and in some cases, deep brain stimulation.
Conclusion
Understanding PD is crucial for healthcare professionals as it aids in early diagnosis and effective management, thereby improving patient outcomes. Continuous research is necessary to unravel the complexities of this disease and develop more effective therapies.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge